Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women
about
Hepatitis B and human immunodeficiency virus co-infectionUpdate on occult hepatitis B virus infectionPrevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of NepalHigh prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern UgandaMaternal hepatitis B and infant infection among pregnant women living with HIV in South Africa.Occult hepatitis B virus infection among Mexican human immunodeficiency virus-1-infected patients.High prevalence of HIV-1 CRF01_AE viruses among female commercial sex workers residing in Surabaya, IndonesiaOccult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance.Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in GabonHigh Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany.Question 1: should newborns of mothers with isolated antibodies to hepatitis B core antigen be immunised?A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052.Hepatitis B virus vaccination in HIV-infected people: A review.Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study.Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: a retrospective observational cohort study.Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era.Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana.
P2860
Q26822862-8962F405-3C0A-486A-9246-C78AF0C66D9BQ28070317-F42B9073-E515-43F1-BEBC-4CF7C1594ABEQ28547151-015336AA-E7AD-417D-BB19-06A176075A59Q28651407-DF305C24-FDC3-4DAB-9AD2-92455F1C22B3Q33655929-52D7092F-3646-4B5C-897E-B42387BA9375Q34303032-5721CA89-492F-4F6A-9134-ACFC699903FEQ35075358-6A4970DD-969F-4262-BE26-5195D87A2AB1Q35127050-7AC835A5-A507-42E5-B32B-23AF51F0334CQ35893639-BD3A6D99-5825-4389-8581-88CD640FD4A9Q36268801-72901D36-16A0-4541-99F9-8402F0796510Q38247272-8140530A-0505-4864-97B0-06A7DF92235FQ38657651-F72AB002-1F03-494C-AFB7-C6B3CF3DBBCBQ39166033-4B8C4DD3-A29D-4270-913F-9BFC3B59980BQ40107327-B8E70525-9DDC-483B-9ABD-47E9BA4267FFQ40528258-13483E4D-E870-4748-ACFC-E05435B0A19CQ41706245-FD2D6339-FCC5-4163-B5A5-61DA33B7760CQ54249544-2AB03D4D-09DF-41F8-9739-69E0441BD5C2Q55030278-7FD38043-A591-40FF-B9C1-CB75807DC9CC
P2860
Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prevalence, risk factors, and ...... HIV-1-infected pregnant women
@en
type
label
Prevalence, risk factors, and ...... HIV-1-infected pregnant women
@en
prefLabel
Prevalence, risk factors, and ...... HIV-1-infected pregnant women
@en
P2093
P2860
P50
P356
P1476
Prevalence, risk factors, and ...... HIV-1-infected pregnant women
@en
P2093
Alain Goudeau
Catherine Gaudy-Graffin
Noossara Puarattana-Aroonkorn
Program for HIV Prevention and Treatment (PHPT-2) group
Sakchai Tonmat
Sirisak Nanta
Tapnarong Jarupanich
Veeradate Chalermpolprapa
Wasna Sirirungsi
Weerapong Suwankornsakul
P2860
P304
P356
10.1093/CID/CIT166
P407
P577
2013-03-13T00:00:00Z